Fig. 1From: Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance dataStudies included in the pooled analysis. ETN etanercept, PBO placebo, UST ustekinumabBack to article page